查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917729

神经復健市场－2026年至2031年预测

Neurorehabilitation Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计神经復健市场将从 2025 年的 18.57 亿美元成长到 2031 年的 36.79 亿美元，复合年增长率为 12.07%。

神经復健市场呈现持续成长的态势，其主要驱动力是临床上迫切需要帮助神经病变患者恢復功能并改善生活品质。人口结构变化、技术创新和不断发展的护理模式的协同效应，进一步推动了这一成长。包括中风、脊髓损伤、帕金森氏症和多发性硬化症在内的神经系统疾病在全球范围内的发病率不断上升，加上人口老化，导致需要高级復健护理的患者群体持续扩大。同时，技术突破正在改变治疗模式，使其不再局限于辅助器具，而是积极促进神经可塑性和復原。

关键市场驱动因素与技术趋势

市场的主要驱动因素是根本性的且相互关联的。人口老化趋势是主要催化剂。人口老化与慢性神经系统疾病和神经退化性疾病发病率的上升密切相关，从而持续催生了对用于解决运动障碍、认知衰退和维持独立生活的设备的需求。同时，全球医疗保健基础设施的扩张和专业化，特别是专业復健中心的建立，也促进了这项需求。这些机构需要各种先进设备来提供全面、多学科的照护。

最具活力的成长要素是技术的融合，因为市场透过多种先进模式的整合而不断发展。

  • 机器人和外骨骼：机器人步态训练器和上肢外骨骼等设备可以提供频繁、重复和生理上精确的运动疗法，从而减轻治疗师的工作量并实现强化训练。
  • 脑机介面（BCI）：BCI 在大脑和外部设备之间建立直接通讯通道，为功能恢復提供了可能，并描述了一种激活神经迴路的新型生物回馈疗法机制。
  • 非侵入性神经刺激：经颅磁刺激 (TMS) 和经颅直流电刺激 (tDCS) 等技术用于调节皮质兴奋性和促进神经可塑性，通常与物理治疗结合使用。
  • 穿戴式感测器和游戏化：穿戴式装置能够持续监测临床环境以外的运动和进展，而游戏化的復健系统透过互动练习提高患者的参与度和留存率。

这些技术的通用关键趋势是人工智慧 (AI) 与数据分析的融合。 AI 演算法分析来自设备感测器的大量资料集，即时个人化治疗通讯协定，预测復健轨迹，并为临床医生提供可操作的见解。这种向数据驱动的精准康復的转变正在提高治疗效果并优化治疗结果。

市场区隔与竞争格局

市场已按设备类型、最终用户和地区进行细分。主要产品类型包括神经机器人系统、脑机介面、穿戴式装置、非侵入式刺激装置和神经復健游戏系统。最终用户包括医院、门诊诊所、专业復健中心以及日益增长的居家照护领域，这凸显了对用户友好、便携且适用于远端监控和远距远端医疗整合的设备的需求。

竞争格局的特点是既有成熟的医疗技术领导企业，也有专注于特定领域的创新公司。像雅培这样的主要企业凭藉其在神经调控领域的深厚专业知识，提供用于治疗慢性疼痛和运动障碍等疾病的植入式和体外神经刺激设备。像Bioness Inc.这样的专业公司则专注于用于肢体復健的可穿戴功能性电刺激（FES）系统，而像Ekso Bionics Holdings, Inc.这样的先驱企业则处于步态训练用机器人外骨骼技术的前沿。这些公司在临床证据、技术水平、整合能力以及成功获得医疗保险报销等方面展开竞争。

地理视角和区域​​优势

北美在全球市场保持主导地位。这项优势源自于多项结构性优势：成熟且先进的医疗保健基础设施，非常适合高成本技术的应用；大规模的老龄人口中神经系统疾病的高发生率；以及复杂但历来支持医疗设备创新的监管和报销环境。此外，该地区还聚集了许多大型医疗设备製造商、研究机构和创业投资，从而建构了一个强大的研发和商业化生态系统。

未来发展及策略意义

神经復健市场预计将持续发展壮大。不可逆转的人口趋势和神经系统疾病盛行率的不断上升，确保了市场规模的持续成长。未来，人工智慧的深度整合、远距復健平台的广泛应用以及更经济实惠、以消费者为中心的家用设备的开发，将共同塑造市场格局。产业相关人员的成功不仅取决于技术优势，还取决于能否在改善功能性结果、成本效益以及与不断发展的护理路径无缝衔接等方面展现出明确的价值。随着人们越来越关注以患者为中心的长期疗效，这些设备将巩固其作为功能復健过程中不可或缺的工具的地位，并将神经復健转变为一个更可衡量、更个性化、更易于获取的领域。

本报告的主要优势

  • 深入分析：获取主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直细分市场和其他子细分市场。
  • 竞争格局：了解全球主要参与企业的策略倡议，并了解透过正确的策略进入市场的潜力。
  • 市场驱动因素与未来趋势：探索推动市场的动态因素和关键趋势，以及它们将如何塑造未来的市场发展。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021-2025年实际数据，2026-2031年预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、重大发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 神经復健产品市场

  • 介绍
  • 神经机器人系统
  • 穿戴式装置
  • 脑机介面
  • 非侵入性刺激器
  • 人工替代物
  • 其他的

第六章 按应用程式分類的神经復健市场

  • 介绍
  • 中风
  • 创伤性脑损伤（TBI）
  • 脊髓损伤（SCI）
  • 帕金森氏症
  • 脑性麻痹
  • 其他的

第七章 按最终使用者分類的神经復健市场

  • 介绍
  • 医院
  • 诊所
  • 復健中心
  • 居家照护环境

第八章 区域性神经復健市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Medtronic plc
  • Abbott Laboratories
  • Bionik Laboratories Corp.
  • Ekso Bionics Holdings, Inc.
  • DIH Medical Group
  • ReWalk Robotics
  • BioXtreme Ltd.
  • Kinova
  • Saebo Inc.

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615682

The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.

The neurorehabilitation devices market is characterized by sustained growth, driven by a critical clinical imperative: enhancing functional recovery and quality of life for individuals with neurological impairments. This expansion is underpinned by a confluence of demographic shifts, technological innovation, and evolving care models. The rising global prevalence of neurological disorders-including stroke, spinal cord injury, Parkinson's disease, and multiple sclerosis-coupled with an ageing population, establishes a persistent and growing patient base requiring advanced rehabilitative care. Concurrently, technological breakthroughs are transforming therapeutic paradigms, moving beyond supportive aids to become active facilitators of neuroplasticity and recovery.

Primary Market Drivers and Technological Trends

Key drivers propelling the market forward are foundational and interrelated. The demographic trend of population ageing is a primary catalyst, as advanced age correlates with a higher incidence of chronic neurological conditions and neurodegenerative diseases. This creates sustained demand for devices that address motor deficits, cognitive decline, and the preservation of independence. Complementing this demand is the global expansion and specialization of healthcare infrastructure, particularly the establishment of dedicated rehabilitation centers. These facilities necessitate a diverse array of sophisticated equipment to deliver comprehensive, multidisciplinary care.

The most dynamic growth vector is technological convergence. The market is evolving through the integration of several advanced modalities:

  • Robotics and Exoskeletons: Devices such as robotic gait trainers and upper-limb exoskeletons provide high-dosage, repetitive, and physiologically accurate movement therapy, reducing therapist burden and enabling intensive training.
  • Brain-Computer Interfaces (BCIs): BCIs create direct communication pathways between the brain and external devices, offering promising avenues for restoring function and providing novel biofeedback mechanisms to engage neural circuits.
  • Non-Invasive Neurostimulation: Techniques including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are used to modulate cortical excitability and promote neuroplasticity, often in conjunction with physical therapy.
  • Wearable Sensors and Gamification: Wearables enable continuous monitoring of movement and progress outside clinical settings, while gamified rehabilitation systems improve patient engagement and adherence through interactive exercises.

A pivotal trend across these technologies is the integration of Artificial Intelligence (AI) and Data Analytics. AI algorithms can analyze vast datasets from device sensors to personalize therapy protocols in real-time, predict recovery trajectories, and provide clinicians with actionable insights. This shift towards data-driven, precision rehabilitation is enhancing treatment efficacy and optimizing therapeutic outcomes.

Market Segmentation and Competitive Landscape

The market is segmented by device type, end-user, and geography. Key product categories include neurorobotic systems, brain-computer interfaces, wearable devices, non-invasive stimulators, and neurorehabilitation gaming systems. End-users span hospitals, outpatient clinics, specialized rehabilitation centers, and a growing home-care segment, which emphasizes the need for devices that are user-friendly, portable, and suitable for remote monitoring and telehealth integration.

The competitive landscape features established medical technology leaders and specialized innovators. Major players like Abbott Laboratories leverage deep expertise in neuromodulation, offering implantable and external neurostimulators for conditions such as chronic pain and movement disorders. Specialized firms such as Bioness Inc. focus on wearable functional electrical stimulation (FES) systems for limb rehabilitation, while pioneers like Ekso Bionics Holdings, Inc. are at the forefront of robotic exoskeleton technology for gait training. These companies compete on clinical evidence, technological sophistication, integration capabilities, and success in navigating reimbursement pathways.

Geographical Outlook and Regional Dominance

North America maintains a dominant position in the global market. This leadership is attributed to several structural advantages: a mature and advanced healthcare infrastructure conducive to adopting high-cost technologies, a high prevalence of neurological disorders within a sizeable ageing population, and a regulatory and reimbursement environment that, while complex, has historically supported innovation in medical devices. Furthermore, the region's concentration of leading device manufacturers, research institutions, and venture capital fosters a robust ecosystem for development and commercialization.

Future Trajectory and Strategic Implications

The neurorehabilitation devices market is poised for continued evolution and growth. The irreversible demographic trends and increasing burden of neurological disorders ensure a durable addressable market. The future will be shaped by the deeper integration of AI, the proliferation of telerehabilitation platforms, and the development of more affordable, consumer-centric devices for home use. Success for industry participants will increasingly depend on demonstrating not only technical superiority but also clear value in improving functional outcomes, cost-effectiveness, and seamless integration into evolving care pathways. As the focus on long-term patient-centric outcomes intensifies, these devices will solidify their role as indispensable tools in the journey toward functional recovery, transforming neurorehabilitation into a more measurable, personalized, and accessible discipline.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Neurorehabilitation Devices Market Segmentation

  • By Type
  • Neurorobotic Systems
  • Brain-Computer Interfaces
  • Wearable Devices
  • Non-Invasive Stimulators
  • Neurorehabilitation Gaming Systems
  • Others
  • By Application
  • Stroke
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Parkinson's Disease
  • Cerebral Palsy
  • Others
  • By End-User
  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Home Care Settings
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEUROREHABILITATION MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Neuro-Robotic System
  • 5.3. Wearable Devices
  • 5.4. Brain Computer Interface
  • 5.5. Non-Invasive Stimulators
  • 5.6. Neuronal Prosthetics
  • 5.7. Others

6. NEUROREHABILITATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Stroke
  • 6.3. Traumatic Brain Injury (TBI)
  • 6.4. Spinal Cord Injury (SCI)
  • 6.5. Parkinson's Disease
  • 6.6. Cerebral Palsy
  • 6.7. Others

7. NEUROREHABILITATION MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Rehabilitation Centers
  • 7.5. Home Care Settings

8. NEUROREHABILITATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Medtronic plc
  • 10.2. Abbott Laboratories
  • 10.3. Bionik Laboratories Corp.
  • 10.4. Ekso Bionics Holdings, Inc.
  • 10.5. DIH Medical Group
  • 10.6. ReWalk Robotics
  • 10.7. BioXtreme Ltd.
  • 10.8. Kinova
  • 10.9. Saebo Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations